[Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion].

xlomafota13 shared this article with you from Inoreader [Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion]. Via Association française pour l'étude du cancer Related Articles [Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion]. Bull Cancer. 2020 Nov;107(11):1085-1086 Authors: Delaye M, Rodrigues M PMID: 33169692 [PubMed - in process] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.